The DOI matches its Crossref record; 82 of the 82 references it cites were found in a registry or an index.
Antibody Structure, Instability, and Formulation
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Shinkawa, T., Nakamura, K., Yamane, N., Shoji-Hosaka, E., Kanda, Y., Sakurada, M., Uchida, K., Anazawa, H., Satoh, M., Yamasaki, M., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210665200 · Cited by 1,413
Lyophilization and development of solid protein pharmaceuticals
Wang, W. (2000) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(00)00423-3 · Cited by 1,175
Self-citationInstability, stabilization, and formulation of liquid protein pharmaceuticals
Wang, W. (1999) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(99)00152-0 · Cited by 1,064
Self-citationAntibody Pharmacokinetics and Pharmacodynamics
Lobo, E. D., Hansen, R. J., & Balthasar, J. P. (2004) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20178 · Cited by 909
Challenges in the development of high protein concentration formulations
Shire, S. J., Shahrokh, Z., & Liu, J. (2004) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20079 · Cited by 882
Rational Design of Stable Lyophilized Protein Formulations: Some Practical Advice
Carpenter, J. F., Pikal, M. J., Chang, B. S., & Randolph, T. W. (1997) · Pharmaceutical Research · doi:10.1023/a:1012180707283 · Cited by 683
Challenges in the Development of High Protein Concentration Formulations
Shire, S. J., Shahrokh, Z., & Liu, J. (2010) · Current Trends in Monoclonal Antibody Development and Manufacturing · doi:10.1007/978-0-387-76643-0_9 · Cited by 657
Structure-Immunogenicity Relationships of Therapeutic Proteins
Hermeling, S., Crommelin, D. J. A., Schellekens, H., & Jiskoot, W. (2004) · Pharmaceutical Research · doi:10.1023/b:pham.0000029275.41323.a6 · Cited by 617
Cleland, J. L., Powell, M., & Shire, S. J. (1993) · PubMed · Cited by 543
Tao, M. H., & Morrison, S. L. (1989) · The Journal of Immunology · doi:10.4049/jimmunol.143.8.2595 · Cited by 530
Identification of multiple sources of charge heterogeneity in a recombinant antibody
Harris, R. J., Kabakoff, B., Macchi, F. D., Shen, F. J., Kwong, M., Andya, J. D., Shire, S. J., Bjork, N., Totpal, K., & Chen, A. B. (2001) · Journal of Chromatography B: Biomedical Sciences and Applications · doi:10.1016/s0378-4347(00)00548-x · Cited by 500
Humanization of an antibody directed against IgE.
Presta, L. G., Lahr, S. J., Shields, R. L., Porter, J. P., Gorman, C. M., Fendly, B. M., & Jardieu, P. M. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.151.5.2623 · Cited by 474
A Simple Method for Improving Protein Solubility and Long-Term Stability
Golovanov, A. P., Hautbergue, G. M., Wilson, S. A., & Lian, L.-Y. (2004) · Journal of the American Chemical Society · doi:10.1021/ja049297h · Cited by 466
Chang, L. (., Shepherd, D., Sun, J., Ouellette, D., Grant, K. L., Tang, X. (., & Pikal, M. J. (2005) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20364 · Cited by 461
Liu, J., Nguyen, M. D. H., Andya, J. D., & Shire, S. J. (2005) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20347 · Cited by 436
Tyler-Cross, R., & Schirch, V. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)54607-x · Cited by 371
Antibodies and Genetically Engineered Related Molecules: Production and Purification
Roque, A. C. A., Lowe, C. R., & Taipa, M. A. (2004) · Biotechnology Progress · doi:10.1021/bp030070k · Cited by 360
Kinetic studies of protein–protein interactions
Schreiber, G. (2002) · Current Opinion in Structural Biology · doi:10.1016/s0959-440x(02)00287-7 · Cited by 323
Effect of glycosylation on antibody function: implications for genetic engineering
Wright, A., & Morrison, S. L. (1997) · Trends in Biotechnology · doi:10.1016/s0167-7799(96)10062-7 · Cited by 312
Induction and analysis of aggregates in a liquid IgG1-antibody formulation
Mahler, H.-C., Müller, R., Frieβ, W., Delille, A., & Matheus, S. (2005) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2004.12.004 · Cited by 309
Cleland, J. L., Lam, X., Kendrick, B., Yang, J., Yang, T., Overcashier, D., Brooks, D., Hsu, C., & Carpenter, J. F. (2001) · Journal of Pharmaceutical Sciences · doi:10.1002/1520-6017(200103)90:3<310::aid-jps6>3.0.co;2-r · Cited by 299
Braun, A., Kwee, L., Labow, M. A., & Alsenz, J. (1997) · Pharmaceutical Research · doi:10.1023/a:1012193326789 · Cited by 298
Peroxide formation in polysorbate 80 and protein stability
Ha, E., Wang, W., & John Wang, Y. (2002) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.10216 · Cited by 286
Self-citationAntioxidants for Prevention of Methionine Oxidation in Recombinant Monoclonal Antibody HER2
Lam, X. M., Yang, J. Y., & Cleland, J. L. (1997) · Journal of Pharmaceutical Sciences · doi:10.1021/js970143s · Cited by 263
The Effect of Operating and Formulation Variables on the Morphology of Spray-Dried Protein Particles
Maa, Y.-F., Costantino, H. R., Nguyen, P.-A., & Hsu, C. C. (1997) · Pharmaceutical Development and Technology · doi:10.3109/10837459709031441 · Cited by 229
Spray-Drying of Air–Liquid Interface Sensitive Recombinant Human Growth Hormone
Maa, Y.-F., Nguyen, P.-A. T., & Hsu, S. W. (1998) · Journal of Pharmaceutical Sciences · doi:10.1021/js970308x · Cited by 211
Inverse Relationship of Protein Concentration and Aggregation
Treuheit, M. J., Kosky, A. A., & Brems, D. N. (2002) · Pharmaceutical Research · doi:10.1023/a:1015108115452 · Cited by 209
Cacia, J., Keck, R., Presta, L. G., & Frenz, J. (1996) · Biochemistry · doi:10.1021/bi951526c · Cited by 202
Chang, L. (., Shepherd, D., Sun, J., Tang, X. (., & Pikal, M. J. (2005) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20363 · Cited by 199
Harris, R. J., Shire, S. J., & Winter, C. (2004) · Drug Development Research · doi:10.1002/ddr.10344 · Cited by 198
Harris, R. J. (1995) · Journal of Chromatography A · doi:10.1016/0021-9673(94)01255-d · Cited by 197
Effect of Moisture on the Stability of a Lyophilized Humanized Monoclonal Antibody Formulation
Breen, E. D., Curley, J. G., Overcashier, D. E., Hsu, C. C., & Shire, S. J. (2001) · Pharmaceutical Research · doi:10.1023/a:1013054431517 · Cited by 196
Glockshuber, R., Schmidt, T., & Plueckthun, A. (1992) · Biochemistry · doi:10.1021/bi00120a002 · Cited by 196
Andya, J. D., Maa, Y.-F., Costantino, H. R., Nguyen, P.-A., Dasovich, N., Sweeney, T. D., Hsu, C. C., & Shire, S. J. (1999) · Pharmaceutical Research · doi:10.1023/a:1018805232453 · Cited by 190
Duddu, S. P., & Dal Monte, P. R. (1997) · Pharmaceutical Research · doi:10.1023/a:1012144810067 · Cited by 173
Andya, J. D., Hsu, C. C., & Shire, S. J. (2003) · AAPS PharmSci · doi:10.1208/ps050210 · Cited by 165
Chen, B., Bautista, R., Yu, K., Zapata, G. A., Mulkerrin, M. G., & Chamow, S. M. (2003) · Pharmaceutical Research · doi:10.1023/b:pham.0000008042.15988.c0 · Cited by 165
The therapeutic antibodies market to 2008
Pavlou, A. K., & Belsey, M. J. (2005) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2004.11.007 · Cited by 153
Secondary Structure and Protein Deamidation
Xie, M., & Schowen, R. L. (1999) · Journal of Pharmaceutical Sciences · doi:10.1021/js9802493 · Cited by 150
Maury, M., MURPHY, K., KUMAR, S., Mauerer, A., & LEE, G. (2004) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2004.07.010 · Cited by 147
Identification of Sites of Degradation in a Therapeutic Monoclonal Antibody by Peptide Mapping
Kroon, D. J., Baldwin-Ferro, A., & Lalan, P. (1992) · Pharmaceutical Research · doi:10.1023/a:1015894409623 · Cited by 145
Stability of crystalline proteins
Shenoy, B. C., Wang, Y., Shan, W., & Margolin, A. L. (2001) · Biotechnology and Bioengineering · doi:10.1002/bit.1069 · Cited by 127
Wörn, A., & Plückthun, A. (1998) · Biochemistry · doi:10.1021/bi980712q · Cited by 126
Zheng, J. Y., & Janis, L. J. (2005) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.10.024 · Cited by 124
Tous, G. I., Wei, Z., Feng, J., Bilbulian, S., Bowen, S., Smith, J., Strouse, R., McGeehan, P., Casas‐Finet, J. R., & Schenerman, M. A. (2005) · Analytical Chemistry · doi:10.1021/ac0500582 · Cited by 113
Welfle, K., Misselwitz, R., Hausdorf, G., Höhne, W., & Welfle, H. (1999) · Biochimica et Biophysica Acta · doi:10.1016/s0167-4838(99)00046-1 · Cited by 111
Preserving dry biomaterials : The water replacement hypothesis, part 2
Crowe, J. H. (1993) · Medical Entomology and Zoology · Cited by 110
Furtado, P. B., Whitty, P. W., Robertson, A. N., et al. (2004) · Journal of Molecular Biology · doi:10.1016/j.jmb.2004.03.007 · Cited by 109
Sukumar, M., Doyle, B. L., Combs, J. L., & Pekar, A. H. (2004) · Pharmaceutical Research · doi:10.1023/b:pham.0000032993.98705.73 · Cited by 108
Stability and characterization of protein and peptide drugs : case histories
Wang, Y. J., & Pearlman, R. (1993) · Cited by 97
Gall, F. L., Reusch, U., Little, M., & Kipriyanov, S. M. (2004) · Protein Engineering Design and Selection · doi:10.1093/protein/gzh039 · Cited by 86
Leibiger, H., Wüstner, D., Stigler, R.-D., & Marx, U. (1999) · Biochemical Journal · doi:10.1042/0264-6021:3380529 · Cited by 84
Antibodies as therapeutic agents: vive la renaissance!
Stockwin, L., & Holmes, S. (2003) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.3.7.1133 · Cited by 84
Wang, L., Amphlett, G. W., Lambert, J. M., Blättler, W. A., & Zhang, W. (2005) · Pharmaceutical Research · doi:10.1007/s11095-005-5267-7 · Cited by 83
Li, S., Bomser, J. A., & Zhang, Q. H. (2005) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf048923r · Cited by 83
Dall’Acqua, W. F., & Carter, P. M. (1998) · Current Opinion in Structural Biology · doi:10.1016/s0959-440x(98)80121-8 · Cited by 83
Antibody structure, prediction and redesign
Morea, V., Tramontano, A. L., Rustici, M., Chothia, C., & Lesk, A. M. (1997) · Biophysical Chemistry · doi:10.1016/s0301-4622(96)02266-1 · Cited by 82
Oliva, B., Bates, P. A., Querol, E., Avilés, F. X., & Sternberg, M. J. E. (1998) · Journal of Molecular Biology · doi:10.1006/jmbi.1998.1847 · Cited by 82
Chemical and Physical Stability of Chimeric L6, a Mouse−Human Monoclonal Antibody
Paborji, M., Pochopin, N. L., Coppola, W. P., & Bogardus, J. B. (1994) · Pharmaceutical Research · doi:10.1023/a:1018948901599 · Cited by 79
Hartmann, W. K., Saptharishi, N., Yang, X. Y., Mitra, G., & Soman, G. (2004) · Analytical Biochemistry · doi:10.1016/j.ab.2003.10.031 · Cited by 78
Reductionism and the search for structure–function relationships in antibody molecules
Regenmortel, M. H. V. V. (2002) · Journal of Molecular Recognition · doi:10.1002/jmr.584 · Cited by 78
Hunt, G., Moorhouse, K. G., & Chen, A. B. (1996) · Journal of Chromatography A · doi:10.1016/0021-9673(96)00437-2 · Cited by 76
Glycation of monoclonal antibodies impairs their ability to bind antigen
KENNEDY, D. M., SKILLBN, A. W., & SELF, C. H. (2008) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.1994.tb06133.x · Cited by 74
Formatting antibody fragments to mediate specific therapeutic functions
Weir, A. N. C., Nesbitt, A. M., Chapman, A. P., Popplewell, A. G., & Lawson, A. D. G. (2002) · Biochemical Society Transactions · doi:10.1042/bst0300512 · Cited by 73
Ressing, M. E., Jiskoot, W., Talsma, H., van Ingen, C. W., Beuvery, E. C., & Crommelin, D. J. A. (1992) · Pharmaceutical Research · doi:10.1023/a:1018905927544 · Cited by 66
The effect of pH, hydrogen peroxide and temperature on the stability of human monoclonal antibody
Usami, A., Ohtsu, A., Takahama, S., & Fujii, T. (1996) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/s0731-7085(96)01721-9 · Cited by 66
Formulation Development of Protein Dosage Forms
Akers, M. J., Vasudevan, V., & Stickelmeyer, M. P. (2002) · Pharmaceutical biotechnology · doi:10.1007/978-1-4615-0549-5_2 · Cited by 63
Contribution of Domain Interface Residues to the Stability of Antibody CH3 Domain Homodimers
Dall’Acqua, W. F., Simon, A. L., Mulkerrin, M. G., & Carter, P. M. (1998) · Biochemistry · doi:10.1021/bi980270i · Cited by 60
Where disease pathogenesis meets protein formulation: Renal deposition of immunoglobulin aggregates
Demeule, B., Gurny, R., & Arvinte, T. (2005) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2005.08.008 · Cited by 60
Patten, P. A., & Schellekens, H. (2003) · PubMed · Cited by 59
Porjazoska, A., Goračinova, K., Mladenovska, K., Dodov, M. G., Simonovska, M., Janjević, E. I., & Cvetkovska, M. (2004) · PubMed · Cited by 43
The use of surface tension measurements in the design of antibody-based product formulations.
Levine, H. L., Ransohoff, T. C., Kawahata, R. T., & McGregor, W. C. (1991) · PubMed · Cited by 38
Ramsland, P. A., & Farrugia, W. (2002) · Journal of Molecular Recognition · doi:10.1002/jmr.585 · Cited by 37
Delivery of Proteins from a Controlled Release Injectable Implant
Yewey, G., Duysen, E. G., Cox, S. M., & Dunn, R. L. (2005) · Kluwer Academic Publishers eBooks · doi:10.1007/0-306-46803-4_3 · Cited by 34
McIntosh, D. P., Cooke, R. J., McLachlan, A. J., Daley‐Yates, P. T., & Rowland, M. (1997) · Journal of Pharmaceutical Sciences · doi:10.1021/js960282u · Cited by 32
Martsev, S. P., Tsybovsky, Y., Stremovskiy, O. A., Odintsov, S. G., Balandin, T. G., Arosio, P., Kravchuk, Z. I., & Deyev, S. M. (2004) · Protein Engineering Design and Selection · doi:10.1093/protein/gzh011 · Cited by 31
Harrison, J. S., Gill, A., & Hoare, M. (1998) · Biotechnology and Bioengineering · Cited by 31
The hinge as a spacer contributes to covalent assembly and is required for function of IgG
Coloma, M. J., Trinh, K. R., Wims, L. A., & Morrison, S. L. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.2.733 · Cited by 26
Powell, M. F., Amphlett, G. W., Cacia, J., Callahan, W., Canova‐Davis, E., Chang, B. S., Cleland, J. L., Darrington, T., DeYoung, L., Dhingra, B., et al. (2002) · Pharmaceutical biotechnology · doi:10.1007/0-306-47452-2_1 · Cited by 24
Ruzheinikov, S. N., Muranova, T. A., Sedelnikova, S. E., Partridge, L. J., Blackburn, G. M., Murray, I. A., Kakinuma, H., Takahashi, N., Shimazaki, K., Sun, J., et al. (2003) · Journal of Molecular Biology · doi:10.1016/s0022-2836(03)00902-1 · Cited by 14
Chan, L. A., Phillips, M. L., Wims, L. A., Trinh, K. R., Denham, J., & Morrison, S. L. (2004) · Molecular Immunology · doi:10.1016/j.molimm.2004.03.034 · Cited by 12
Formulation Development of an Antifibrin Monoclonal Antibody Radiopharmaceutical
Kamat, M. S., Tolman, G. L., & Brown, J. M. (2002) · Pharmaceutical biotechnology · doi:10.1007/0-306-47452-2_9 · Cited by 11
Cited by
Extrinsic Fluorescent Dyes as Tools for Protein Characterization
Hawe, A., Sutter, M., & Jiskoot, W. (2008) · Pharmaceutical Research · doi:10.1007/s11095-007-9516-9 · Cited by 1,199
Protein aggregation: Pathways, induction factors and analysis
Mahler, H.-C., Friess, W., Grauschopf, U., & Kiese, S. (2009) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21566 · Cited by 901
Effects of glycosylation on the stability of protein pharmaceuticals
Solá, R. J., & Griebenow, K. (2009) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21504 · Cited by 646
Cancer acidity: An ultimate frontier of tumor immune escape and a novel target of immunomodulation
Huber, V., Camisaschi, C., Berzi, A., Ferro, S., Lugini, L., Triulzi, T., Tuccitto, A., Tagliabue, E., Castelli, C., & Rivoltini, L. (2017) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2017.03.001 · Cited by 595
The structural basis of antibody–antigen recognition
Sela-Culang, I., Kunik, V., & Ofran, Y. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00302 · Cited by 530
Metadata
- Authors
- Wang, W., Singh, S., Zeng, D. L., King, K., & Nema, S.
- Venue
- Journal of Pharmaceutical Sciences
- Publisher
- Elsevier BV
- Published
- 2007-01
- Volume
- 96
- Issue
- 1
- Pages
- 1-26
- ISSN
- 0022-3549 (ISSN-L)
- OpenAlex
- W2073948759
- Cited by
- 941
- References
- 82
- FWCI
- 8.84
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.